Antisickling activity of sodium cromoglicate in sickle-cell disease

被引：18

作者：

Toppet, M

Fall, ABK

Ferster, A

Fondu, P

Mélot, H

Vanhaelen-Fastré, R

Vanhaelen, M ^{[1
]}

机构：

[1] Free Univ Brussels, Inst Pharm, Lab Pharmacognosie & Bromatol, B-1050 Brussels, Belgium

[2] Hop Univ Des Enfants Reine Fabiola, Unite Hamatooncol, Brussels, Belgium

[3] Free Univ Brussels, Hop Univ Brugmann, Hematol Lab, B-1050 Brussels, Belgium

[4] Free Univ Brussels, Hop Univ Erasme, Serv Soins Intens, B-1050 Brussels, Belgium

来源：

LANCET | 2000年 / 356卷 / 9226期

关键词：

D O I：

10.1016/S0140-6736(00)02508-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Two groups of patients with sickle-cell disease were given a single dose of sodium cromoglicate by inhalation or nasal route. The striking decrease in sickle cells after treatment by both routes lends support to the role of sodium cromoglicate in sickle-cell disease treatment.

引用

页码：309 / 309

页数：1

共 5 条

[1] Mechanisms of disease - Pathogenesis and treatment of sickle cell disease [J].